432 related articles for article (PubMed ID: 31196609)
1. Ion channels and transporters in diabetic kidney disease.
Spires D; Manis AD; Staruschenko A
Curr Top Membr; 2019; 83():353-396. PubMed ID: 31196609
[TBL] [Abstract][Full Text] [Related]
2. Development and internal validation of machine learning algorithms for end-stage renal disease risk prediction model of people with type 2 diabetes mellitus and diabetic kidney disease.
Zou Y; Zhao L; Zhang J; Wang Y; Wu Y; Ren H; Wang T; Zhang R; Wang J; Zhao Y; Qin C; Xu H; Li L; Chai Z; Cooper ME; Tong N; Liu F
Ren Fail; 2022 Dec; 44(1):562-570. PubMed ID: 35373711
[TBL] [Abstract][Full Text] [Related]
3. Effects of metabolic memory on inflammation and fibrosis associated with diabetic kidney disease: an epigenetic perspective.
Zheng W; Guo J; Liu ZS
Clin Epigenetics; 2021 Apr; 13(1):87. PubMed ID: 33883002
[TBL] [Abstract][Full Text] [Related]
4. Role of TRPC6 in Progression of Diabetic Kidney Disease.
Staruschenko A; Spires D; Palygin O
Curr Hypertens Rep; 2019 May; 21(7):48. PubMed ID: 31115705
[TBL] [Abstract][Full Text] [Related]
5. What's New in the Molecular Mechanisms of Diabetic Kidney Disease: Recent Advances.
Watanabe K; Sato E; Mishima E; Miyazaki M; Tanaka T
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614011
[TBL] [Abstract][Full Text] [Related]
6. Unraveling the Role of Inflammation in the Pathogenesis of Diabetic Kidney Disease.
Matoba K; Takeda Y; Nagai Y; Kawanami D; Utsunomiya K; Nishimura R
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31295940
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA: an emerging player in diabetes and diabetic kidney disease.
Guo J; Liu Z; Gong R
Clin Sci (Lond); 2019 Jun; 133(12):1321-1339. PubMed ID: 31221822
[TBL] [Abstract][Full Text] [Related]
8. SGLT2 Inhibition for the Prevention and Treatment of Diabetic Kidney Disease: A Review.
Alicic RZ; Johnson EJ; Tuttle KR
Am J Kidney Dis; 2018 Aug; 72(2):267-277. PubMed ID: 29866460
[TBL] [Abstract][Full Text] [Related]
9. Emerging Role of Ferroptosis in Diabetic Kidney Disease: Molecular Mechanisms and Therapeutic Opportunities.
Wang H; Liu D; Zheng B; Yang Y; Qiao Y; Li S; Pan S; Liu Y; Feng Q; Liu Z
Int J Biol Sci; 2023; 19(9):2678-2694. PubMed ID: 37324941
[TBL] [Abstract][Full Text] [Related]
10. Protective role of Trpc6 knockout in the progression of diabetic kidney disease.
Spires D; Ilatovskaya DV; Levchenko V; North PE; Geurts AM; Palygin O; Staruschenko A
Am J Physiol Renal Physiol; 2018 Oct; 315(4):F1091-F1097. PubMed ID: 29923767
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial dynamics and diabetic kidney disease: Missing pieces for the puzzle of therapeutic approaches.
Narongkiatikhun P; Chattipakorn SC; Chattipakorn N
J Cell Mol Med; 2022 Jan; 26(2):249-273. PubMed ID: 34889040
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic modification in diabetic kidney disease.
Liu Z; Liu J; Wang W; An X; Luo L; Yu D; Sun W
Front Endocrinol (Lausanne); 2023; 14():1133970. PubMed ID: 37455912
[TBL] [Abstract][Full Text] [Related]
13. Diabetic Nephropathy: An Overview.
Sagoo MK; Gnudi L
Methods Mol Biol; 2020; 2067():3-7. PubMed ID: 31701441
[TBL] [Abstract][Full Text] [Related]
14. Mitochondria in Diabetic Kidney Disease.
Ahmad AA; Draves SO; Rosca M
Cells; 2021 Oct; 10(11):. PubMed ID: 34831168
[TBL] [Abstract][Full Text] [Related]
15. Human carnosinase 1 overexpression aggravates diabetes and renal impairment in BTBR
Qiu J; Albrecht T; Zhang S; Hauske SJ; Rodriguez-Niño A; Zhang X; Nosan D; Pastene DO; Sticht C; Delatorre C; van Goor H; Porubsky S; Krämer BK; Yard BA
J Mol Med (Berl); 2020 Sep; 98(9):1333-1346. PubMed ID: 32803273
[TBL] [Abstract][Full Text] [Related]
16. Reducing VEGF-B Signaling Ameliorates Renal Lipotoxicity and Protects against Diabetic Kidney Disease.
Falkevall A; Mehlem A; Palombo I; Heller Sahlgren B; Ebarasi L; He L; Ytterberg AJ; Olauson H; Axelsson J; Sundelin B; Patrakka J; Scotney P; Nash A; Eriksson U
Cell Metab; 2017 Mar; 25(3):713-726. PubMed ID: 28190774
[TBL] [Abstract][Full Text] [Related]
17. Diabetic kidney disease: a report from an ADA Consensus Conference.
Tuttle KR; Bakris GL; Bilous RW; Chiang JL; de Boer IH; Goldstein-Fuchs J; Hirsch IB; Kalantar-Zadeh K; Narva AS; Navaneethan SD; Neumiller JJ; Patel UD; Ratner RE; Whaley-Connell AT; Molitch ME
Am J Kidney Dis; 2014 Oct; 64(4):510-33. PubMed ID: 25257325
[TBL] [Abstract][Full Text] [Related]
18. Lower bile acids as an independent risk factor for renal outcomes in patients with type 2 diabetes mellitus and biopsy-proven diabetic kidney disease.
Xiao X; Zhang J; Ji S; Qin C; Wu Y; Zou Y; Yang J; Zhao Y; Yang Q; Liu F
Front Endocrinol (Lausanne); 2022; 13():1026995. PubMed ID: 36277729
[TBL] [Abstract][Full Text] [Related]
19. The genetic side of diabetic kidney disease: a review.
Song J; Ni J; Yin X
Int Urol Nephrol; 2023 Feb; 55(2):335-343. PubMed ID: 35974289
[TBL] [Abstract][Full Text] [Related]
20. STIM promotes the epithelial-mesenchymal transition of podocytes through regulation of FcγRII activity in diabetic nephropathy.
Jin J; Ye M; Hu K; Gong J; He Q
Histol Histopathol; 2019 Jun; 34(6):671-682. PubMed ID: 30475382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
